StockData
Bio Key International Inc logo

Bio Key International Inc (BKYI) stock

BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/3073% below fair value
$1.94−0.15 (-7.18%)

Close on Nov 17, 2026Market cap $2.79MP/E –Yield –

Bio Key International operating margin

Operating margin is operating income as a percentage of revenue.

Bio Key International's operating margin for the twelve months ending Jun 30, 2026 was -86.4%. For fiscal 2025 it was -115.0%, against -57.9% the year before. The highest annual figure on record is 0.7% in fiscal 2012.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-115.0%−57.1
FY2024Dec 31, 2024-57.9%+55.9
FY2023Dec 31, 2023-113.8%+27.5
FY2022Dec 31, 2022-141.4%−44.7
FY2021Dec 31, 2021-96.6%+86.8
FY2020Dec 31, 2020-183.4%−136.3
FY2019Dec 31, 2019-47.1%−47.1
FY2018Dec 31, 20180.0%+67.8
FY2017Dec 31, 2017-67.8%+73.4
FY2016Dec 31, 2016-141.2%−109.0
FY2015Dec 31, 2015-32.2%+18.7
FY2014Dec 31, 2014-50.9%+76.1
FY2013Dec 31, 2013-127.0%−127.7
FY2012Dec 31, 20120.7%+42.2
FY2011Dec 31, 2011-41.5%−7.4
FY2010Dec 31, 2010-34.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-27.6%+36.3
Q1 FY2026Mar 31, 2026-7.4%+32.5
Q4 FY2025Dec 31, 2025-388.5%−301.9
Q3 FY2025Sep 30, 2025-57.6%−30.5
Q2 FY2025Jun 30, 2025-63.9%+81.1
Q1 FY2025Mar 31, 2025-39.9%−16.5
Q4 FY2024Dec 31, 2024-86.7%+62.6
Q3 FY2024Sep 30, 2024-27.1%+81.1
Q2 FY2024Jun 30, 2024-144.9%−21.6
Q1 FY2024Mar 31, 2024-23.3%+57.2
Q4 FY2023Dec 31, 2023-149.2%+134.9
Q3 FY2023Sep 30, 2023-108.2%+63.7
Q2 FY2023Jun 30, 2023-123.3%−42.8
Q1 FY2023Mar 31, 2023-80.5%−29.0
Q4 FY2022Dec 31, 2022-284.1%−70.3
Q3 FY2022Sep 30, 2022-171.9%−95.3
Q2 FY2022Jun 30, 2022-80.5%+31.6
Q1 FY2022Mar 31, 2022-51.5%−7.2
Q4 FY2021Dec 31, 2021-213.8%−80.2
Q3 FY2021Sep 30, 2021-76.5%+39.0
Q2 FY2021Jun 30, 2021-112.1%−46.7
Q1 FY2021Mar 31, 2021-44.3%+348.1
Q4 FY2020Dec 31, 2020-133.6%−59.6
Q3 FY2020Sep 30, 2020-115.5%+7.8
Q2 FY2020Jun 30, 2020-65.4%−49.6
Q1 FY2020Mar 31, 2020-392.4%−392.4
Q4 FY2019Dec 31, 2019-74.0%−394.0
Q3 FY2019Sep 30, 2019-123.4%+98.5
Q2 FY2019Jun 30, 2019-15.8%+205.5
Q1 FY2019Mar 31, 20190.0%+260.5
Q4 FY2018Dec 31, 2018320.0%+304.4
Q3 FY2018Sep 30, 2018-221.9%−51.5
Q2 FY2018Jun 30, 2018-221.3%−19.5
Q1 FY2018Mar 31, 2018-260.5%−164.9
Q4 FY2017Dec 31, 201715.6%+46.1
Q3 FY2017Sep 30, 2017-170.4%+106.5
Q2 FY2017Jun 30, 2017-201.8%–
Q1 FY2017Mar 31, 2017-95.6%–
Q4 FY2016Dec 31, 2016-30.5%–
Q3 FY2016Sep 30, 2016-276.9%–

More Bio Key International figures

See a number that looks wrong?